Columbia Asset Management raised its stake in Waters Corporation (NYSE:WAT) by 6.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,581 shares of the medical instruments supplier’s stock after buying an additional 385 shares during the quarter. Columbia Asset Management’s holdings in Waters Corporation were worth $1,209,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of WAT. BlackRock Inc. lifted its stake in Waters Corporation by 2,810.7% in the first quarter. BlackRock Inc. now owns 5,349,711 shares of the medical instruments supplier’s stock valued at $836,212,000 after buying an additional 5,165,917 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its stake in Waters Corporation by 3,735.4% in the first quarter. Nomura Asset Management Co. Ltd. now owns 373,950 shares of the medical instruments supplier’s stock valued at $58,452,000 after buying an additional 364,200 shares during the last quarter. Janus Capital Management LLC lifted its stake in Waters Corporation by 18.2% in the first quarter. Janus Capital Management LLC now owns 2,309,646 shares of the medical instruments supplier’s stock valued at $361,021,000 after buying an additional 356,395 shares during the last quarter. Fundsmith LLP lifted its stake in Waters Corporation by 11.3% in the first quarter. Fundsmith LLP now owns 3,432,535 shares of the medical instruments supplier’s stock valued at $536,540,000 after buying an additional 349,178 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Waters Corporation by 3.0% in the first quarter. Vanguard Group Inc. now owns 7,497,760 shares of the medical instruments supplier’s stock valued at $1,171,975,000 after buying an additional 216,162 shares during the last quarter. Institutional investors own 91.12% of the company’s stock.

In other Waters Corporation news, Director Christopher A. Kuebler sold 3,500 shares of the business’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the transaction, the director now owns 17,849 shares of the company’s stock, valued at $3,206,929.83. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 5.07% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/10/columbia-asset-management-buys-385-shares-of-waters-corporation-wat.html.

Shares of Waters Corporation (NYSE WAT) traded up 0.91% during midday trading on Friday, hitting $186.56. 505,369 shares of the company were exchanged. Waters Corporation has a one year low of $133.35 and a one year high of $187.65. The firm has a market cap of $14.89 billion, a P/E ratio of 28.12 and a beta of 0.83. The company’s 50 day moving average price is $179.49 and its 200 day moving average price is $172.27.

Waters Corporation (NYSE:WAT) last posted its quarterly earnings data on Tuesday, July 25th. The medical instruments supplier reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.05. The company had revenue of $558.30 million for the quarter, compared to analyst estimates of $553.22 million. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.58 earnings per share. Equities analysts expect that Waters Corporation will post $7.38 EPS for the current year.

A number of equities research analysts have issued reports on WAT shares. Bank of America Corporation reiterated a “neutral” rating and issued a $192.00 target price (up from $180.00) on shares of Waters Corporation in a research note on Friday, July 21st. Wells Fargo & Company reiterated an “outperform” rating and issued a $205.00 target price (up from $195.00) on shares of Waters Corporation in a research note on Thursday, July 13th. Jefferies Group LLC reiterated a “hold” rating and issued a $170.00 target price on shares of Waters Corporation in a research note on Friday, July 14th. Zacks Investment Research cut Waters Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Finally, Cowen and Company reiterated a “hold” rating and issued a $190.00 target price on shares of Waters Corporation in a research note on Friday, July 14th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $186.00.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Stock Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related stocks with our FREE daily email newsletter.